Case Western Reserve University and the Cleveland Clinic are developing a computerized tissue imaging capability that uses predictive analytics to potentially help identify which lung cancer patients are likely to experience an earlier recurrence of the disease.
The National Cancer Institute (NCI) recently awarded Anant Madabhushi, founding director of the Center for Computational Imaging and Personalized Diagnostics at the Case School of Engineering, and his colleagues a $3.2 million grant to more accurately determine which early-stage lung cancer patients would most benefit from chemotherapy following surgery, and which would not.
